Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crispr Therapeutics Ag
(NQ:
CRSP
)
54.84
+1.61 (+3.02%)
Streaming Delayed Price
Updated: 2:34 PM EDT, Jul 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crispr Therapeutics Ag
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
28
29
Next >
CRISPR Therapeutics (CRSP) Stock Jumps as U.K. Authorizes Gene Therapy
November 16, 2023
CRSP stock is up on U.K. authorization for its gene therapy treatment for sickle cell anemia. CRISPR hopes for FDA authorization next spring.
Via
InvestorPlace
Exposures
Product Safety
UK Approves First Crispr Gene Edited Therapy For Sickle Cell Disease, Beta Thalassemia
November 16, 2023
The U.K.
Via
Benzinga
Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
November 16, 2023
Shares of Palo Alto Networks, Inc. (NASDAQ: PANW) fell in pre-market trading after reporting first-quarter results.
Via
Benzinga
Can CRISPR Therapeutics Stock Double in 5 Years? Here's What It Would Take.
November 16, 2023
A few things put together could push the stock higher.
Via
The Motley Fool
Vertex and CRISPR Therapeutics Announce Authorization of the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), by the United Kingdom MHRA for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
November 16, 2023
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Why CRISPR Therapeutics Stock Could Be About to Take Off
November 08, 2023
CRISPR's financial prospects could soon get an upgrade.
Via
The Motley Fool
Invest in the Future With These 7 Forever Stocks
November 15, 2023
Forever stocks are usually those predicting future trends. Finding them today means pinning down strong financials and prospects without FOMO.
Via
InvestorPlace
3 Biotech Stocks With Key Catalysts Coming in December
November 15, 2023
Some of the most exciting opportunities can be found in biotech stocks, especially if there's a powerful catalyst just around the corner.
Via
InvestorPlace
2 Stocks to Buy Hand Over Fist as the S&P 500 Rockets Higher
November 14, 2023
These stocks look reasonably priced today considering their long-term prospects.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
What's Going On With CRISPR Therapeutics Stock?
November 13, 2023
CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Monday after Morgan Stanley maintained the company with an Underweight rating and lowered the price target. What To Know:
Via
Benzinga
3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024
November 12, 2023
Investors should consider these "Goldilocks" biotech stocks to buy as they are poised to get significant boosts next year.
Via
InvestorPlace
Why CRISPR Therapeutics Stock Charged Northward This Week
November 03, 2023
Gene correction technology took a big step forward this week.
Via
The Motley Fool
1 No-Brainer Stock to Buy and Hold for 10 Years
November 11, 2023
This company has been in the news for much of the year.
Via
The Motley Fool
3 Growth Stocks to Buy Right Now Without Any Hesitation
November 11, 2023
Investors shouldn't have to deliberate for too long about these great stocks.
Via
The Motley Fool
Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review
November 10, 2023
The major indexes ended long win streaks. Datadog led earnings winners.
Via
Investor's Business Daily
3 Biotech Stocks That Are Betting on the Future of Gene Editing
November 09, 2023
These three companies have gene editing therapies in late-stage clinical trials, making them promising biotech stocks to buy right now.
Via
InvestorPlace
This Program for a Common Problem May Be Vertex Pharmaceuticals' Ticket to a New Wave of Billion-Dollar Revenues
November 09, 2023
Vertex shares look cheap today considering all the company has to offer.
Via
The Motley Fool
3 Biotech Stocks With the Strongest Clinical Pipelines
November 08, 2023
Many industry heavyweights are on the hunt for fresh new ideas -- great news for biotech stocks to buy with strong pipelines.
Via
InvestorPlace
CRISPR Therapeutics Stock Earns IBD Stock Rating Upgrade
November 08, 2023
On Wednesday, CRISPR Therapeutics stock had its Relative Strength (RS) Rating upgraded to 85, up from 68 a day earlier.
Via
Investor's Business Daily
Why you can make Vertex Pharmaceuticals a buy on any pullback
November 08, 2023
Vertex stock is off its all-time highs after a slight miss on revenue, but the company's robust pipeline gives investors a reason to watch VRTX stock closely
Via
MarketBeat
Exposures
COVID-19
Why CRISPR Therapeutics Stock Crushed the Market Today
November 07, 2023
Investors were cheered by the company's latest earnings release, coupled with operational updates.
Via
The Motley Fool
Vertex Slouches After Tech Leader Reports Mixed Results; But Late-Stage Pipeline In Focus
November 07, 2023
The company expects $9.85 billion in full-year sales of its cystic fibrosis treatments.
Via
Investor's Business Daily
Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners
November 06, 2023
Roku vaulted 50% to become Ark Innovation's top holding.
Via
Investor's Business Daily
Why CRISPR Therapeutics Stock Is Moving Higher Monday
November 06, 2023
CRISPR Therapeutics AG (NYSE: CRSP) shares are trading higher Monday after the company announced preclinical data for its investigational programs for the
Via
Benzinga
2 Magnificent Growth Stocks That Might Be Badly Mispriced Right Now
November 05, 2023
These two beaten-down growth stocks could be brilliant buys for risk-tolerant investors.
Via
The Motley Fool
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
November 03, 2023
Bulls are back in control as the major indexes confirmed the uptrend this week.
Via
Investor's Business Daily
Here's What Investors Need to Know About Vertex Pharmaceuticals and CRISPR Therapeutics' Big Day at the FDA
November 03, 2023
The meeting went almost as well as could be expected.
Via
The Motley Fool
3 Healthcare Stocks to Buy Hand Over Fist in November
November 03, 2023
Get these stocks while they're cheap.
Via
The Motley Fool
One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?
November 02, 2023
This stock could be a long-term winner, thanks to its game-changing technology.
Via
The Motley Fool
Why Are Stocks Up Today?
November 01, 2023
Stocks are up today as investors prepare for the most recent information from the Federal Reserve concerning interest rates.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.